SCHEMBL19801320

SCHEMBL19801320

Cc1cc(-c2ccccn2)ccc1-c1ccccc1-c1cc(-c2ccccc2-c2ccc(-c3ccccn3)cc2C)cc(S(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.40
NPC1 O15118 2/20 0.37
KDM4E B2RXH2 1/20 0.37
PTGS2 P35354 2/20 0.37
PTGS1 P23219 1/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
SCD O00767 1/20 0.36
TGFBR1 P36897 1/20 0.35
KAT6A Q92794 1/20 0.35
WNT3A P56704 2/20 0.35
MITF O75030 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
EDNRB P24530 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015380 0.88 PDK2 (0.45) PDK2NPC1KDM4ETGFBR1WNT3A
SCHEMBL18015279 0.84 PDK2 (0.42) PDK2NPC1KDM4ETGFBR1WNT3A
SCHEMBL21202867 0.84 PDK2 (0.42) PDK2NPC1KDM4ETGFBR1WNT3A
SCHEMBL23240025 0.84 PDK2 (0.42) PDK2NPC1KDM4ETGFBR1WNT3A
SCHEMBL23239881 0.84 CCR1 (0.44) PDK2NPC1KDM4EPTGS2PTGS1
SCHEMBL18015684 0.83 TGFBR1 (0.46) PDK2NPC1KDM4ETGFBR1RAB9A
SCHEMBL19794351 0.83 PDK2 (0.41) PDK2NPC1KDM4ETGFBR1WNT3A
SCHEMBL19801347 0.82 PDK2 (0.40) PDK2NPC1KDM4ETGFBR1WNT3A
SCHEMBL18015275 0.82 PDK2 (0.40) PDK2NPC1KDM4ETGFBR1WNT3A
SCHEMBL18015493 0.78 TGFBR1 (0.45) PDK2NPC1KDM4ETGFBR1WNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC PDK2 3655/4885NPC1 4039/4885KDM4E 3894/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 PDK2 2111/4885NPC1 2761/4885KDM4E 3864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.